The Role of A20 in Cancer: Friend or Foe?

Related Experiment Video

Updated: May 14, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.5K

Jinju Lee1, Heesun Cheong1

  • 1Division of Cancer Biology, Research Institute, National Cancer Center, Goyang-si 10408, Republic of Korea.

Cells
|April 11, 2025
PubMed

Insights

The ubiquitin-editing enzyme A20 has dual roles in cancer, acting as an oncogene or tumor suppressor. Its interplay with autophagy influences tumor progression and suppression, offering therapeutic insights.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • A20 is a ubiquitin-editing enzyme regulating inflammatory signaling.
  • A20 exhibits context-dependent roles in cancer, acting as both an oncogene and tumor suppressor.
  • A20 influences critical cellular pathways including NF-κB signaling and autophagy.

Purpose of the Study:

  • To review the dual roles of A20 in tumorigenesis.
  • To highlight A20's interplay with autophagy in cancer.
  • To provide insights into therapeutic interventions targeting A20 dysregulation.

Main Methods:

  • Literature review of recent findings on A20 in cancer.
  • Analysis of A20's modulation of NF-κB signaling and autophagy.
  • Integration of data on A20's context-specific functions.

Main Results:

  • A20 promotes tumor progression in breast cancer and melanoma.
  • A20 acts as a tumor suppressor in lymphomas and hepatocellular carcinoma.
  • Dysregulation of A20 and autophagy impacts cancer development.

Conclusions:

  • A20's paradoxical roles in cancer are linked to its regulation of inflammatory signaling and autophagy.
  • Understanding A20's dual functions is crucial for developing targeted cancer therapies.
  • Targeting A20 pathways may offer novel strategies for cancer treatment.
Keywords:
A20/TNFAIP3autophagycancer

More Related Videos

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

9.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

389

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K